50 likes | 62 Views
Global Oligonucleotide Synthesis Market size was valued at USD 4.1 Billion in 2021 and is poised to grow from USD 4.60 Billion in 2022 to USD 11.46 Billion by 2030, at a CAGR of 12.10% during the forecast period (2023-2030).<br><br>
E N D
Global Oligonucleotide Synthesis Market Size, Share, Growth Analysis, By End-use, By Application- Industry Forecast 2023-2030 Global Oligonucleotide Synthesis Market size was valued at USD 4.1 Billion in 2021 and is poised to grow from USD 4.60 Billion in 2022 to USD 11.46 Billion by 2030, at a CAGR of 12.10% during the forecast period (2023-2030). The purpose of the oligonucleotide synthesis market is to provide researchers, scientists, and manufacturers with custom-made and pre-manufactured oligonucleotides for various applications, including gene synthesis, PCR, DNA sequencing, diagnostics, and therapeutics. The increasing demand for synthetic biology and personalized medicine is the primary driving factor for the oligonucleotide synthesis market. The increasing prevalence of cancer and genetic disorders is also boosting the demand for oligonucleotides in the market. The oligonucleotide synthesis market faces several challenges, including quality control, regulatory compliance, and ethical concerns related to gene synthesis. The increasing complexity of oligonucleotide synthesis and the need
for specialized equipment and expertise pose significant challenges to market players. The oligonucleotide synthesis market presents several opportunities for market players, including the development of new and innovative oligonucleotide synthesis technologies, the expansion of the application areas for oligonucleotides, and the increasing demand for personalized medicine and gene therapy. The oligonucleotide synthesis market is expected to continue its growth trajectory in the coming years, driven by the increasing demand for synthetic biology and personalized medicine. However, the market may face challenges related to cost, technical expertise, quality control, and regulatory compliance.
Global Oligonucleotide Synthesis Market Segmental Analysis The global oligonucleotide synthesis market is segmented on the basis of end-use, application, and region. Based on categorization by end-use, the market is segmented into Academic Research Institutes, Diagnostic Laboratories, and Pharmaceutical - Biotechnology Companies. In terms of categorization by application, the market is segmented into PCR Primers, PCR Assays and Panels, Sequencing, DNA Microarrays, Fluorescence in Situ Hybridization (FISH), Antisense Oligonucleotides, and Other Applications. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. View-More https://www.skyquestt.com/report/oligonucleotide- synthesis-market
Oligonucleotide Synthesis Market Top Player’s Company Profiles •Agilent Technologies, Inc. (US) •BioAutomation Corporation (US) •Biosearch Technologies, Inc. (US) •Biolytic Lab Performance Inc. (Canada) •Eurofins Genomics LLC (US) •General Electric Company (US) •GenScript Biotech Corporation (China) •Integrated DNA Technologies, Inc. (US) •Kaneka Eurogentec S.A. (Belgium) •LGC Limited (UK) •Merck KGaA (Germany) •Nitto Denko Avecia Inc. (US) •Thermo Fisher Scientific Inc. (US) •TriLink BioTechnologies, LLC (US) •Twist Bioscience Corporation (US) •ATDBio Ltd. (UK) •Axil Scientific Pte Ltd. (Singapore) •Biogen International GmbH (Switzerland) •Biomer Technology LLC (US) •Bio-Synthesis, Inc. (US)
About Us: SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally. Address: 1 Apache Way, Westford, Massachusetts 01886 Phone: USA (+1) 617-230-0741 Email: sales@skyquestt.com LinkedIn Facebook Twitter